![Richard Batycky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 35 $ al 31/05/2026
Richard P.
Batycky was the founder of Civitas Therapeutics, Inc., founded in 2009, where the title held was Chief Scientific Officer from 2009 to 2014.
Current jobs include President, Chief Executive Officer & Director at Nocion Therapeutics, Inc. since 2018; Director at Pulmatrix Operating Co., Inc. since 2007; and Independent Director at Pulmatrix, Inc. since 2019.
Former jobs include Vice President at Alkermes, Inc. from 1999 to 2013; Chief Technology Officer at Acorda Therapeutics, Inc.; and Principal at Advanced Inhalation Research, Inc. Education includes undergraduate degree from the University of Calgary and graduate and doctorate degrees from the Massachusetts Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/02/2026 | 25 ( 0 % ) | 35 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PULMATRIX, INC. | Director/Miembro de la Junta | 01/11/2019 |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Director/Miembro de la Junta | - |
Nocion Therapeutics, Inc.
 Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Director Ejecutivo | 01/08/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Fundador | 01/11/2014 |
| ACORDA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Advanced Inhalation Research, Inc.
 Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Develops dry-powder drug delivery system for respiratory patients | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Advanced Inhalation Research, Inc.
Advanced Inhalation Research, Inc. Pharmaceuticals: MajorHealth Technology Develops dry-powder drug delivery system for respiratory patients | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
